Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach.
BACKGROUND: Overactive bladder (OAB) affects the lives of millions of people worldwide and antimuscarinics are the pharmacological treatment of choice. Meta-analyses of all currently used antimuscarinics for treating OAB found similar efficacy, making the choice dependent on their adverse event prof...
Main Authors: | Thomas M Kessler, Lucas M Bachmann, Christoph Minder, David Löhrer, Martin Umbehr, Holger J Schünemann, Alfons G H Kessels |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3044140?pdf=render |
Similar Items
-
An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
by: Anastasios Athanasopoulos, et al.
Published: (2011-01-01) -
The challenge of overactive bladder therapy: alternative to antimuscarinic agents
by: Massimo Lazzeri, et al.
Published: (2006-12-01) -
Effect of Antimuscarinic Drugs on Cognitive Functions in the Management of Overactive Bladder in Elderly
by: Ervandy Rangganata, et al.
Published: (2020-10-01) -
Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
by: Bilal Chughtai, et al.
Published: (2008-09-01) -
Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom.
by: Andrea V Margulis, et al.
Published: (2018-01-01)